Loading…

Thieno[2,3-d]pyrimidine as a promising scaffold in medicinal chemistry: Recent advances

[Display omitted] •Comprehensive review on thieno[2,3-d]pyrimidine scaffold.•Detailed presentation of different synthetic pathways of Thieno[2,3-d]pyrimidines.•Anticancer activity and SAR of compounds containing thieno[2,3-d]pyrimidine.•Kinases inhibitory effect of thieno[2,3-d]pyrimidine derivative...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry 2019-04, Vol.27 (7), p.1159-1194
Main Authors: Ali, Eslam M.H., Abdel-Maksoud, Mohammed S., Oh, Chang-Hyun
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[Display omitted] •Comprehensive review on thieno[2,3-d]pyrimidine scaffold.•Detailed presentation of different synthetic pathways of Thieno[2,3-d]pyrimidines.•Anticancer activity and SAR of compounds containing thieno[2,3-d]pyrimidine.•Kinases inhibitory effect of thieno[2,3-d]pyrimidine derivatives.•Biological activities of thieno[2,3-d]pyrimidines were reported. Thienopyrimidine scaffold is a fused heterocyclic ring system that structurally can be considered as adenine, the purine base that is found in both DNA and RNA-bioisosteres. Thienopyrimidines exist in three distinct isomeric forms. The current review discusses thieno[2,3-d]pyrimidine as a one of the opulent heterocycles in drug discovery. Its broad range of medical applications such as anticancer, anti-inflammatory, anti-microbial, and CNS protective agents has inspired us to study its structure-activity relationship (SAR), along with its relevant synthetic strategies. The present review briefly summarizes synthetic approaches for the preparation of thieno[2,3-d]pyrimidine derivatives. In addition, the promising biological activities of this scaffold are also illustrated with explanatory diagrams for their SAR studies.
ISSN:0968-0896
1464-3391
DOI:10.1016/j.bmc.2019.02.044